Clinical Trials Logo

Clinical Trial Summary

Perivascular epithelioid cell tumors (PEComas) are rare and are characterized by the expression of myomelanocytic markers. They are a complex family that includes angiomyolipomas, lymphangioleiomyomatoses and other soft tissue and visceral tumors. Due to the low prevalence of these tumors, the natural history is unclear; furthermore, a molecular classification integrating clinical, pathological and molecular parameters has not been described to date.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Perivascular Epithelioid Cell Neoplasms

NCT number NCT05617105
Study type Observational
Source University Hospital, Strasbourg, France
Contact Gabriel MALOUF, MD, PhD
Phone 33 3 88 11 51 41
Email malouf.gabriel@chru-strasbourg.fr
Status Recruiting
Phase
Start date December 1, 2019
Completion date December 31, 2022